Search results
Hyperkalaemia in Heart Failure
Author(s):
Umar Ismail
,
Kiran Sidhu
,
Shelley Zieroth
Added:
2 years ago
Article
Author(s):
Fraser J Graham
,
Antonio Iaconelli
,
Piotr Sonecki
,
et al
Added:
9 months ago
Author(s):
Veronika Zach
,
Felix Lucas Bähr
,
Frank Edelmann
Added:
4 years ago
Heart failure (HF) is a chronic, progressive disease with steadily increasing incidence rates and high morbidity and mortality that represents a major challenge in healthcare worldwide.1–3 The disease is characterised by chronic exacerbations, recurrent hospitalisations and poor prognosis.1,2 Survival rates in HF patients are lower than in patients suffering from some malignant diseases,…
View more
Author(s):
Josip Katic
,
Josip A Borovac
Added:
11 months ago
Author(s):
Hans-Peter Brunner-La Rocca
,
Sandra Sanders-van Wijk
Added:
3 years ago
Natriuretic peptides (NPs) are well established in the diagnostic process of heart failure (HF). Low levels of NPs are particularly useful to exclude heart failure (HF). Numerous studies, predominantly in patients presenting with acute onset of symptoms suspected of HF, have convincingly shown the value of NPs in this regard. A meta-analysis published in 2015 clearly summarised the value of brain…
View more
Author(s):
Gian Franco Gensini
,
Camilla Alderighi
,
Raffaele Rasoini
,
et al
Added:
3 years ago
Telehealth is a multiform term embracing the applications of telematics to medicine, in order to enable diagnosis and/or treatment remotely through a set of communication tools, including phones, smartphones and mobile wireless devices, with or without a video connection.1
Until a few years ago, digital applications in medicine were restricted to the use of data obtained from electronic health…
View more
Author(s):
Ovidiu Chioncel
,
Sean P Collins
,
Stephen J Greene
,
et al
Added:
3 years ago
Hospitalisation is a critical event in the clinical course of heart failure (HF) and despite relatively rapid relief of symptoms, hospitalisation is followed by an increased risk of death and re-hospitalisation.1 While performance measures have been developed in the last few years with the intent of improving post-discharge outcomes, post-discharge mortality rates remain unchanged or have…
View more
Author(s):
Patrik Bachtiger
,
Carla M Plymen
,
Punam A Pabari
,
et al
Added:
3 years ago
Although cardiovascular disease is the leading cause of death globally, an increasing proportion of patients are surviving with heart failure (HF), which is substantially increasing in incidence and prevalence.1,2 In the management of HF the indications for implanted devices have widened, resulting in more patients living with an expanding variety of sensor-enabled implanted devices than any…
View more
Author(s):
Milton Packer
Added:
3 years ago
Patients with a broad range of systemic inflammatory rheumatic diseases (i.e. rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis and ankylosing spondylitis) are exceptionally prone to cardiovascular disorders, but previous work concerning the development of heart disease in these individuals has largely focused on the risk of MI.
However, the most important cardiovascular…
View more
Author(s):
Mauro Gori
,
James L Januzzi
,
Emilia D’Elia
,
et al
Added:
2 years ago